Omniab Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.48, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Omniab Inc in Jun 30 2026 quarter, has decreased to 81 days, compared to 83 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 459 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2233 to 3214.

What is Receivable Turnover Ratio?
What is Omniab Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OABI Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	261.49 %	95.11 %	40.17 %	-11.44 %	-54.83 %
Y / Y Revenue Change	244.24 %	247.3 %	-22.47 %	-46.33 %	-48.82 %
Receivable Turnover Ratio (TTM)	4.48	4.41	3.72	4.7	5.02
OABI's Total Ranking	# 3214	# 2233	# 2896	# 3073	#
Accounts Receivable average collection period days	82	83	98	78	73
Seq. Receivable Change	-11.16 %	71.03 %	138.77 %	-0.35 %	-52.05 %
Seq. Revenue Change	-7.01 %	72.24 %	274.1 %	-42.55 %	-6.19 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 28
Healthcare Sector	# 460
Overall Market	# 3214

Receivable Turnover Ratio Statistics
High	Average	Low
0.2	0.1	0.06
(Mar 31 2023)		(Mar 31 2024)

OABI Company Profile • Back to OABI Efficiency Comparisons • Compare OABI Receivables Turnover Ratio to its Competitors

Financial Statements
Omniab Inc 's Accounts Receivable	$ 11 Millions	Visit OABI's Balance sheet
Omniab Inc 's Sales TTM	$ 38 Millions	Visit OABI's Income Statement
Sources of OABI's Revenues		Visit OABI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OABI's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OABI's Growth Rates	OABI's Roa	OABI's Inventory Turnover Ratio	OABI's Dividend Comparisons
OABI's Profitability Ratios	OABI's Roi	OABI's Asset Turnover Ratio	OABI's Dividend Growth
OABI's Valuation Ratios	OABI's Roe	OABI's Financial Strength Ratios	OABI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
Neuronetics Inc	9.24	$ 154.594 Millions	$ 16.732 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
The Pennant Group Inc	9.15	$ 1,101.710 Millions	$ 120.457 Millions
Lexicon Pharmaceuticals Inc	9.14	$ 41.469 Millions	$ 4.535 Millions
Bioaffinity Technologies Inc	9.11	$ 5.901 Millions	$ 0.648 Millions
Nuvation Bio Inc	9.05	$ 169.551 Millions	$ 18.737 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biocryst Pharmaceuticals Inc	9.00	$ 940.613 Millions	$ 104.543 Millions
Biofrontera Inc	8.88	$ 45.956 Millions	$ 5.178 Millions
Novavax inc	8.86	$ 413.796 Millions	$ 46.693 Millions
Grail Inc	8.85	$ 165.263 Millions	$ 18.670 Millions
Guardant Health Inc	8.84	$ 1,183.105 Millions	$ 133.772 Millions
Scientific Industries Inc	8.83	$ 5.728 Millions	$ 0.649 Millions
Sanara Medtech Inc	8.76	$ 110.116 Millions	$ 12.568 Millions
Cannapharmarx Inc	8.65	$ 1.699 Millions	$ 0.196 Millions
Fate Therapeutics Inc	8.64	$ 6.491 Millions	$ 0.751 Millions
Septerna Inc	8.64	$ 98.882 Millions	$ 11.445 Millions
10x Genomics Inc	8.63	$ 616.566 Millions	$ 71.463 Millions
Cg Oncology Inc	8.61	$ 6.228 Millions	$ 0.724 Millions
Tactile Systems Technology Inc	8.58	$ 350.319 Millions	$ 40.851 Millions
Pediatrix Medical Group Inc	8.54	$ 1,950.625 Millions	$ 228.297 Millions
Volitionrx Limited	8.50	$ 2.458 Millions	$ 0.289 Millions
Ensign Group Inc	8.50	$ 5,486.708 Millions	$ 645.470 Millions
Inogen Inc	8.47	$ 354.304 Millions	$ 41.817 Millions
Axogen inc	8.42	$ 251.174 Millions	$ 29.846 Millions
Pulse Biosciences Inc	8.35	$ 1.185 Millions	$ 0.142 Millions
Alpha Teknova Inc	8.33	$ 43.407 Millions	$ 5.208 Millions

Date modified: 2026-09-05T15:23:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.